Respiratory cancer risks associated with low-level nickel exposure: an integrated assessment based on animal, epidemiological, and mechanistic data
Introduction
Nickel (Ni) in various forms is used in a wide range of products, including electric batteries, catalytic converters for automobiles, coins, and innumerable items containing stainless steel and other nickel alloys. In the production of nickel and nickel-bearing products, workers are often exposed to nickel and nickel compounds in the form of airborne dust and small particles. Epidemiological studies conducted on more than 100,000 nickel workers indicate that inhalation of certain nickel compounds can significantly increase lung and nasal sinus cancer risk if the exposure is sufficiently high. Increased respiratory risks have been observed predominantly in workers in dusty, high-exposure refinery processes, most of which are no longer in use today. Less than 8% of the workers that have been studied were exposed to these high-exposure operations with airborne nickel concentrations of more than 1–10 mg Ni/m3, depending on nickel compound. By contrast, little, if any evidence of increased respiratory cancer risk has been found in more than 90,000 workers with substantially lower nickel exposures, including those engaged in nickel mining and smelting, nickel alloy production, and the use of metallic nickel.
The purpose of this paper is to investigate whether the lack of evidence of respiratory cancer risk in most nickel workers (as compared to those involved in high-exposure refinery processes that are largely obsolete) is simply the result of a proportionally lower level of exposure and a lack of statistical power to detect small, but relevant risks, or whether there is evidence to suggest strongly non-linear or threshold carcinogenic responses to nickel and its compounds. In the latter case, cancer risks at relatively low occupational exposures would be non-existent or vanishingly small. Human epidemiology, current occupational exposure measurements, animal bioassay data, and mechanistic theory are used to explore the relative merits of these two propositions.
Section snippets
Summary of respiratory cancer risk in workers exposed to nickel
More than 25 epidemiological studies have been conducted on workers engaged in the production and use of nickel. In several cases, a sequence of studies of the same cohort of workers has been conducted over time, providing updated information as the amount of follow-up on workers increased (Table 1a, Table 1b). In 1985, the International Committee on Nickel Carcinogenesis in Man (ICNCM), chaired by Sir Richard Doll, initiated a comprehensive update and examination of most of these studies. This
Smoking as a potential confounding factor in evaluation of lung cancer risk in nickel workers
Interpretation of marginally increased lung cancer risks in occupational cohort studies is frequently difficult, given the prominent role that tobacco smoking plays in inducing lung cancer. This is particularly true when estimated occupational lung cancer risks are based on comparisons to lung cancer rates in national, provincial, or state reference populations. As smoking prevalence in blue-collar workers is often substantially higher than that of the general population, lung cancer SMRs of up
Consistency of respiratory cancer risks at low nickel exposures with those at higher exposures
As indicated in Fig. 1 and Table 5, crude linear extrapolation of the lung cancer risks in the high-exposure cohorts to those with much lower exposure produces risk estimates that are statistically consistent with those that have been observed in these cohorts. The resulting estimated excess risks, while small relative to those of more highly exposed workers, are in some cases unacceptably high (e.g., ⩾10−3). The lower 95% confidence limits on these estimates are also consistent with an
Differences in respiratory cancer risks among nickel compounds
The determination of cancer risks associated with low-level exposure to aerosols is further complicated by epidemiological and animal-based evidence that nickel compounds differ in terms of their carcinogenic potency and perhaps potential, as well. The ICNCM (1990) indicated that some of the strongest epidemiological evidence of increased lung and nasal cancer risk was associated with exposure to sulfidic nickel, particularly nickel subsulfide (Ni3S2). This compound does not occur naturally,
Correspondence between epidemiological findings and animal experimentation results
Qualitatively, the animal bioassay responses are consistent with the epidemiological evidence, which suggests that the highest nickel-related occupational respiratory cancer risks were associated with high levels of nickel subsulfide exposure in refinery workers (ICNCM, 1990). The threshold-like tumor response to nickel oxide in rats also conforms in a general sense to the increased lung cancer risks found in workers exposed to high levels of oxidic nickel in outdated refinery processes, and
Discussion
The question of whether low-level exposure to nickel compounds in today’s workplaces results in unacceptable increases in lung cancer risk cannot be answered satisfactorily on the basis of human or animal data alone. Data from epidemiological studies of nickel workers are insufficient to answer the question because of the uncertainties associated with confounding exposures to known respiratory cancer hazards such as smoking, inadequate measurement of past exposures, mixtures of exposures to
Acknowledgements
This work was supported by the Nickel Producers Environmental Research Association.
References (69)
- et al.
Biochemical responses of rats and mouse lung to inhaled nickel compounds
Toxicology
(1989) - et al.
Dose response for formaldehyde-induced cytotoxicity in the human respiratory tract
Regul. Toxicol. Pharmacol.
(2002) - et al.
Factors influencing the phagocytosis, neoplastic transformation, and cytotoxicity of particulate nickel compounds in tissue culture systems
Toxciol. Appl. Pharmacol.
(1981) - et al.
Modeling of deposition and clearance of inhaled Ni compounds in the human lung
Regul. Toxicol. Pharmacol.
(1999) Measuring the projected public health impact of lung cancer through lifetime and age-conditional risk estimates
Ann. Epidemiol.
(2000)- et al.
Carcinogenicity assessment of selected nickel compounds
Toxicol. Appl. Pharmacol.
(1997) Bioassay design and MTD setting: old methods and new approaches
Regul. Toxicol. Pharmacol.
(1995)- et al.
Worker exposure to inhalable and ‘total’ aerosol during nickel alloy production
Ann. Occup. Hyg.
(1996) - ACGIH, 2001. Threshold Limit Values and Biological Exposure Indices for Chemical Substances and Physical Agents....
- et al.
Exposure to nickel compounds and smoking in relation to incidence of lung and nasal cancer among nickel refinery workers
Occup. Environ. Med.
(1996)